Categories: Food

DAHON’s Global Expansion: A Call to Collaborate on New Opportunities

TIANJIN, China, Nov. 27, 2025 /PRNewswire/ — DAHON, the world’s biggest maker of folding bicycles, jumped on its Hong Kong trading debut with the IPO of its subsidiary, DAHON Tech (Stock Code: 02543.HK), on the Main Board of the Hong Kong Stock Exchange.

- Advertisement -

With an oversubscription rate of 7,558 times, media recognized it as Hong Kong’s most oversubscribed listing ever.

- Advertisement -

This successful listing fuelled DAHON with stronger capital foundation to advance its mission in green mobility innovations. Its first major initiative called for a strategic alliance with Golden Wheel Group to establish the new company Dagold Technology in Tianjin, China.  

- Advertisement -

 

- Advertisement -

The new plant will offer regional cost advantages for manufacturing entry-level product lines, enabling DAHON to broaden its market reach and meet diverse consumer needs.

- Advertisement -

To maximize value for its stakeholders, DAHON announced its growth trajectory in three core directions:

- Advertisement -
  1. Building a Global Elite Team
    To engage top international consulting firms to refine its global brand presence, digital marketing strategies, and comprehensive planning to exert stronger market influence.
  2. Technological Upgrade and R&D Cultivation
    To solidify talent development initiatives with strengthened partnership with universities, aiming to nurture high-caliber professionals in bicycle manufacturing.
  3. Expansion of the DELTECH Technological Ecosystem
    DAHON’s proprietary DELTECH technology significantly enhances the rigidity of bike frames, offering a competitive edge in speed and performance. The patented technology will serve as the foundation to uplift all product lines to the next level.
  4. Collaborative Opportunities in the Industry
    Actively pursuing partnerships with distinguished companies worldwide in several key areas:
    • R&D Institutions for technical cooperation.
    • Distributors and Agents for exclusive product rights and co-branding opportunities.
    • High-Quality Suppliers to strengthen its supply chain and enhance service standards.
    • Recruitment of Talented Professionals
      With three PhDs already in DAHON’s R&D Team, DAHON seeks to attract outstanding research and management talent globally, committed to its global development.

Why Choose DAHON?

- Advertisement -
  • Leading the Market: Ranked first in global folding bike sales in 2024 and holds the most folding bicycle patents in China.
  • Proven Resilience: Strong performance even in challenging markets speaks to its robustness.
  • Capital Endorsement: The successful listing in Hong Kong boasted a solid lineup of cornerstone investors and substantial cash flow.

For inquiries, please contact:

- Advertisement -

DAHON Marketing
Email: marketing@dahon.com

- Advertisement -

Photo – https://mma.prnewswire.com/media/2832639/image_1.jpg 
Photo – https://mma.prnewswire.com/media/2832640/image_2.jpg 
Photo – https://mma.prnewswire.com/media/2832641/image_3.jpg 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/dahons-global-expansion-a-call-to-collaborate-on-new-opportunities-302627253.html

- Advertisement -
PRNW Agency

Recent Posts

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated

ZUG, Switzerland, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Ms. Kazem brings extensive and global expertise…

3 weeks ago

Novartis Vanrafia Phase III data support slowing of kidney function decline in patients with IgA nephropathy

Basel, February 13, 2026 – Novartis today announced final results from the Phase III ALIGN…

3 weeks ago

January Commercial Chapter 11 Filings Increase 76% Over 2025

NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- There were 956 commercial Chapter 11 filings…

4 weeks ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

Basel, February 6, 2026 – Novartis today broke ground on a new, state-of-the-art global Biomedical…

1 month ago

Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjgrens disease

Basel, January 16, 2026 – Novartis today announced that the US Food and Drug Administration (FDA)…

2 months ago

Personar Appoints Former Genius Sports COO Eric Stevens as Chief Operating Officer to Scale Award-Winning Sports Technology Platform

Tuesday 13 January, 2026 LONDON – Tuesday, January 13, 2026 – Personar, the AI sports…

2 months ago